SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Medi-Caps informs about closure of trading window

Medi-Caps Ltd. | Chemicals | Chemicals & Fertilizers | BSE: 523144 | NSE: MEDICAPS

26 Jun 2025 Evaluate

With reference to the BSE Circular Ref. No. LIST/COMP/01/2019-20 dated 02nd April, 2019, Medi-Caps has informed that in terms of the Company’s Code of Conduct to regulate, monitor and report trading in Company’s Securities by Insiders Framed under SEBI (Prohibition of Insider Trading) Regulations 2015, the Trading Window for dealing in the securities of the Company will remain closed for all Designated Persons, their immediate relatives and all connected persons (as defined in the Code) with effect from 1st July, 2025 for the purpose of consideration of Unaudited Standalone and consolidated Financial Results for the Quarter ended 30th June, 2025. Further the company has informed that it has also complied with the requirements of Securities and Exchange Board of India (SEBI) Circular No. SEBI/HO/ISD/ISD-SEC-4/P/CIR/2022/107 dated August 5, 2022 and SEBI/HO/ISD/ISDPoD-2/P/CIR/2023/124 dated July 19, 2023, regarding Trading Window Closure period under Clause 4 of Schedule B read with Regulation 9 of SEBI (Prohibition of Insider Trading) Regulations, 2015 (‘PIT Regulations’) framework for restricting trading by Designated Persons (‘DPs’) by freezing PAN at security level. The Trading Window shall open 48 hours after the Unaudited Standalone and consolidated Financial Results for the Quarter ended 30th June, 2025, become generally available i.e. declaration of these Results to the Stock Exchange. All the Directors, KMP’s, Designated Employees, Connected Persons, Fiduciaries and their immediate relatives are advised not to deal in the securities of the Company either directly or indirectly during the aforesaid period. Further, it has submitted the above said information in XBRL mode (excel template provided by Exchange) along with the submission in PDF mode within prescribed time limit. The date of meeting of the Board of Directors to approve the Un-Audited Standalone and Consolidated Financial Results of the Company for the quarter ended on 30th June, 2025 will be intimated in due course.

The above information is a part of company’s filings submitted to BSE.

Medi-Caps Share Price

28.60 0.99 (3.59%)

10-Apr-2026 16:59 View Price Chart

Peers

Company Name	CMP
BASF India	3611.60
Tata Chemicals	690.25
SRF	2471.15
Pidilite Inds.	1360.30
Deepak Nitrite	1465.55
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Medi-Caps informs about closure of trading window

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.